DEFINIUM
Live / Applied — New application — not yet assigned to an examiner (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 03 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99632097
- Mark type
- Stylized text
- Filed
- 03 Feb 2026
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of substance-use and addictive disorders
- Class 042 — Scientific and technological services: Drug discovery services; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the fields of psychiatry, neurology, and addiction medicine; medical and scientific research, namely, conducting clinical trials for others in the field of psychedelic-based therapeutics
Owner
- Definium Therapeutics US, Inc., New York, NY, US
Prosecution history
- 03 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Feb 2026 — NEW APPLICATION ENTERED